Back to search

National and Kapodistrian University of Athens

Μελέτη και κλινική αξιολόγηση νέων μοριακών δεικτών μεθυλίωσης DNA στον καρκίνο

Abstract

dc:description

Epigenetic inactivation of tumor suppressor and cancer related genes contributes to the development of many neoplastic diseases. Hypermethylation appears to occur early during carcinogenesis and its detection is very promising for the early detection of cancer, its prognosis and the design of novel therapeutics. The aims of the present work were a) to study DNA methylation in BRMS1 and SOX17 gene promoter region in order to investigate the prognostic significance of BRMS1 and SOX17 methylation status in early and advanced NSCLC. b) to study DNA methylation in SOX17 and APC gene promoter methylation in order to evaluate their prognostic significance in early colon and gastric cancer. The selection of these genes was based on studies showing them to play an important role in tumor suppression. According to our results BRMS1 promoter was highly methylated both in operable NSCLC primary tissues (59.6%) and corresponding cfDNA (47.9%) but not in cfDNA from healthy individuals (0%), while it was also highly methylated in cfDNA from advanced NSCLC patients (63.5%). In operable NSCLC, Kaplan-Meier estimates were significantly different in favor of patients with non-methylated BRMS1 promoter in cfDNA, concerning both DFI (p=0.048) and OS (p=0.007).Similarly, SOX17 promoter was fully methylated in operable NSCLC primary tissues (100%) and highly methylated in corresponding cfDNA (56.2%) but not in cfDNA from healthy individuals (0%), while it was also methylated in cfDNA from advanced NSCLC patients (36.4%).APC was also highly methylated in adjuvant colon cancer patients 53/127 (41.7%) and in 36/67 (53.7%) of patients with metastasis. The methylation status was correlated with poor survival in both groups of patients (p=0.000).

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Balgkouranidou, Ioanna
  • Μπαλγκουρανίδου, Ιωάννα

Subjects

dc:subject × 24

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/44192

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Balgkouranidou, Ioanna; Μπαλγκουρανίδου, Ιωάννα. Μελέτη και κλινική αξιολόγηση νέων μοριακών δεικτών μεθυλίωσης DNA στον καρκίνο. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/44192